TSHA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.70%

Insider Buying (Last 12 Months): $2,999,999.25

Insider Selling (Last 12 Months): $0.00

Taysha Gene Therapies Insider Trading History Chart

Taysha Gene Therapies Share Price & Price History

^$1.93

▲ +0.05 (2.66%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Taysha Gene Therapies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/27/2024	Paul B. Manning	Major Shareholder	Buy	1,333,333	$2.25	$2,999,999.25	1,333,333
11/17/2023	Paul B. Manning	Major Shareholder	Buy	100,000	$1.63	$163,000.00	16,566,667
8/24/2023	Kamran Alam	CFO	Sell	33,000	$2.33	$76,890.00	258,042
8/16/2023	John A Stalfort III	Director	Buy	388,889	$0.90	$350,000.10	999,381
8/16/2023	Paul B. Manning	Major Shareholder	Buy	16,466,667	$0.90	$14,820,000.30	16,466,667
8/16/2023	Sean P. Nolan	CEO	Buy	444,444	$0.90	$399,999.60	1,535,545
7/12/2023	R.A. Session, II	Major Shareholder	Sell	80,528	$0.71	$57,174.88	8,877,091
6/22/2023	R.A. Session, II	Major Shareholder	Sell	10,508	$0.70	$7,355.60	8,975,719
6/20/2023	R.A. Session, II	Major Shareholder	Sell	295,653	$0.71	$209,913.63	9,125,189
5/16/2023	Sukumar Nagendran	Insider	Buy	5,000	$0.68	$3,400.00	34,226
10/31/2022	Paul B. Manning	Director	Buy	1,500,000	$2.00	$3,000,000.00	1,642,202
8/22/2022	Kamran Alam	CFO	Sell	9,717	$3.50	$34,009.50	269,446
8/18/2022	Kamran Alam	CFO	Sell	7,476	$3.87	$28,932.12	290,645
7/5/2022	Suyash Prasad	CMO	Sell	3,905	$3.51	$13,706.55	539,545
7/1/2022	Suyash Prasad	CMO	Sell	23,923	$3.53	$84,448.19	543,450
6/29/2022	Suyash Prasad	CMO	Sell	12,324	$3.81	$46,954.44	581,265

See Full Table

SEC Filings (Institutional Ownership Changes) for Taysha Gene Therapies (NASDAQ:TSHA)

77.70% of Taysha Gene Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Taysha Gene Therapies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	585,594	$1.01M	0.0%	+26.4%	0.286%
2/17/2025	VR Adviser LLC	3,225,180	$5.58M	0.4%	-64.2%	1.574%
2/17/2025	Squarepoint Ops LLC	211,842	$0.37M	0.0%	+105.4%	0.103%
2/17/2025	RTW Investments LP	8,672,630	$15M	0.2%	-42.0%	4.232%
2/17/2025	Rafferty Asset Management LLC	252,257	$0.44M	0.0%	N/A	0.123%
2/17/2025	Polar Capital Holdings Plc	3,000,000	$5.19M	0.0%	-0.8%	1.464%
2/17/2025	ProShare Advisors LLC	59,076	$0.10M	0.0%	+32.3%	0.029%
2/17/2025	Nuveen Asset Management LLC	546,414	$0.95M	0.0%	-3.6%	0.267%
2/17/2025	Octagon Capital Advisors LP	10,450,000	$18.08M	3.0%	+128.6%	5.099%
2/17/2025	Millennium Management LLC	151,614	$0.26M	0.0%	N/A	0.074%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	108,604	$0.19M	0.0%	+23.3%	0.053%
2/17/2025	Granahan Investment Management LLC	1,636,381	$2.83M	0.1%	+43.6%	0.798%
2/17/2025	Ground Swell Capital LLC	14,660	$25K	0.0%	N/A	0.007%
2/17/2025	First Manhattan CO. LLC.	28,500	$49K	0.0%	N/A	0.014%
2/17/2025	Deutsche Bank AG	151,083	$0.26M	0.0%	-94.1%	0.074%
2/17/2025	DAFNA Capital Management LLC	522,500	$0.90M	0.2%	N/A	0.255%
2/17/2025	Bank of America Corp DE	1,710,303	$2.96M	0.0%	+1,178.9%	0.835%
2/17/2025	BNP Paribas Financial Markets	23,644	$41K	0.0%	N/A	0.012%
2/17/2025	Ameriprise Financial Inc.	22,993	$40K	0.0%	N/A	0.011%
2/17/2025	Acuta Capital Partners LLC	884,244	$1.53M	1.5%	-58.3%	0.431%
2/14/2025	Jane Street Group LLC	169,575	$0.29M	0.0%	+57.6%	0.083%
2/14/2025	Northern Trust Corp	1,458,732	$2.52M	0.0%	+6.3%	0.712%
2/14/2025	Aquatic Capital Management LLC	78,246	$0.14M	0.0%	N/A	0.038%
2/14/2025	Virtus ETF Advisers LLC	31,597	$55K	0.0%	+43.0%	0.015%
2/14/2025	Adage Capital Partners GP L.L.C.	5,000,000	$8.65M	0.0%	N/A	2.440%
2/14/2025	Hsbc Holdings PLC	20,391	$36K	0.0%	+65.6%	0.010%
2/14/2025	Avoro Capital Advisors LLC	19,999,999	$34.60M	0.5%	+7.2%	9.759%
2/14/2025	B Group Inc.	965,556	$1.67M	1.0%	N/A	0.471%
2/14/2025	Tower Research Capital LLC TRC	51,085	$88K	0.0%	+268.8%	0.025%
2/14/2025	MetLife Investment Management LLC	62,990	$0.11M	0.0%	-17.2%	0.031%
2/13/2025	Marshall Wace LLP	138,111	$0.24M	0.0%	-71.6%	0.067%
2/13/2025	Mariner LLC	58,342	$0.10M	0.0%	+337.5%	0.028%
2/13/2025	Barclays PLC	335,238	$0.59M	0.0%	+35.6%	0.164%
2/13/2025	Renaissance Technologies LLC	878,448	$1.52M	0.0%	N/A	0.429%
2/13/2025	ADAR1 Capital Management LLC	177,707	$0.31M	0.1%	-29.3%	0.087%
2/13/2025	Wells Fargo & Company MN	103,384	$0.18M	0.0%	+43.7%	0.050%
2/12/2025	Geode Capital Management LLC	3,572,349	$6.18M	0.0%	+0.3%	1.743%
2/12/2025	Wellington Management Group LLP	585,594	$1.01M	0.0%	+26.4%	0.286%
2/12/2025	Norges Bank	1,461,120	$2.53M	0.0%	N/A	0.713%
2/12/2025	JPMorgan Chase & Co.	2,643,755	$4.57M	0.0%	-11.9%	1.290%
2/11/2025	EntryPoint Capital LLC	61,495	$0.11M	0.0%	+127.5%	0.030%
2/11/2025	Vanguard Group Inc.	8,906,764	$15.41M	0.0%	+7.8%	4.346%
2/11/2025	LPL Financial LLC	60,000	$0.10M	0.0%	N/A	0.029%
2/11/2025	AXQ Capital LP	22,432	$39K	0.0%	N/A	0.011%
2/11/2025	Virtu Financial LLC	107,544	$0.19M	0.0%	N/A	0.052%
2/11/2025	Privium Fund Management B.V.	134,900	$0.23M	0.1%	+12.4%	0.066%
2/10/2025	Cibc World Markets Corp	16,405	$28K	0.0%	N/A	0.008%
2/10/2025	Commonwealth Equity Services LLC	59,069	$0.10M	0.0%	+110.4%	0.029%
2/7/2025	E Fund Management Co. Ltd.	17,844	$31K	0.0%	N/A	0.009%
2/6/2025	Charles Schwab Investment Management Inc.	474,257	$0.82M	0.0%	+2.5%	0.231%
2/4/2025	Los Angeles Capital Management LLC	137,460	$0.24M	0.0%	-33.6%	0.067%
2/4/2025	Bank of New York Mellon Corp	450,261	$0.78M	0.0%	+33.1%	0.220%
1/30/2025	Quantum Private Wealth LLC	794,976	$1.38M	0.4%	+3.6%	0.388%
1/17/2025	SG Americas Securities LLC	28,498	$49K	0.0%	-55.5%	0.014%
12/26/2024	JPMorgan Chase & Co.	3,001,397	$6.03M	0.0%	+1.3%	1.465%
12/19/2024	Principal Financial Group Inc.	15,799	$32K	0.0%	-26.9%	0.008%
11/27/2024	Franklin Resources Inc.	100,795	$0.20M	0.0%	N/A	0.049%
11/19/2024	Barclays PLC	247,280	$0.51M	0.0%	+356.0%	0.121%
11/16/2024	Geode Capital Management LLC	3,562,758	$7.16M	0.0%	+23.7%	1.738%
11/15/2024	Barclays PLC	247,280	$0.51M	0.0%	+356.0%	0.121%
11/15/2024	Jane Street Group LLC	107,572	$0.22M	0.0%	-16.0%	0.052%
11/15/2024	Wellington Management Group LLP	463,192	$0.93M	0.0%	N/A	0.226%
11/15/2024	State Street Corp	3,469,068	$6.97M	0.0%	+4.5%	1.693%
11/15/2024	RTW Investments LP	14,946,420	$30.04M	0.4%	-20.5%	7.293%
11/14/2024	Acuta Capital Partners LLC	2,118,992	$4.26M	3.4%	-9.1%	1.034%
11/14/2024	MetLife Investment Management LLC	76,037	$0.15M	0.0%	+81.9%	0.037%
11/13/2024	FMR LLC	18,678,527	$37.54M	0.0%	-11.9%	9.114%
11/13/2024	The Manufacturers Life Insurance Company	60,665	$0.12M	0.0%	-54.5%	0.030%
11/12/2024	Charles Schwab Investment Management Inc.	462,867	$0.93M	0.0%	+7.7%	0.226%
11/9/2024	Intech Investment Management LLC	42,094	$85K	0.0%	N/A	0.021%
11/5/2024	GSA Capital Partners LLP	233,560	$0.47M	0.0%	+64.7%	0.114%
11/4/2024	Los Angeles Capital Management LLC	206,992	$0.42M	0.0%	N/A	0.101%
11/2/2024	Privium Fund Management B.V.	120,000	$0.24M	0.1%	+21.8%	0.059%
11/1/2024	Quantum Private Wealth LLC	767,616	$1.54M	0.5%	+5.1%	0.375%
10/25/2024	China Universal Asset Management Co. Ltd.	39,417	$79K	0.0%	+79.4%	0.019%
10/11/2024	Creative Planning	14,118	$28K	0.0%	N/A	0.007%
10/3/2024	SG Americas Securities LLC	63,984	$0.13M	0.0%	N/A	0.034%
8/15/2024	Scientech Research LLC	43,350	$97K	0.0%	N/A	0.023%
8/15/2024	The Manufacturers Life Insurance Company	133,213	$0.30M	0.0%	+109.0%	0.071%
8/14/2024	Squarepoint Ops LLC	80,255	$0.18M	0.0%	-62.5%	0.043%
8/14/2024	Marshall Wace LLP	786,094	$1.76M	0.0%	-23.7%	0.420%
8/12/2024	Marathon Trading Investment Management LLC	45,340	$0.10M	0.0%	-79.7%	0.024%
8/9/2024	Renaissance Technologies LLC	41,100	$92K	0.0%	-87.5%	0.022%
8/1/2024	Rhumbline Advisers	184,284	$0.41M	0.0%	N/A	0.099%
8/1/2024	Privium Fund Management B.V.	98,500	$0.21M	0.1%	N/A	0.053%
7/29/2024	Principal Financial Group Inc.	21,609	$48K	0.0%	N/A	0.012%
7/26/2024	Bank of New York Mellon Corp	454,464	$1.02M	0.0%	N/A	0.243%
7/17/2024	Quantum Private Wealth LLC	730,520	$1.64M	0.6%	+4.6%	0.391%
5/17/2024	RA Capital Management L.P.	10,872,503	$31.20M	0.4%	-41.1%	5.814%
5/17/2024	Artal Group S.A.	3,687,548	$10.58M	0.3%	+0.7%	1.972%
5/15/2024	Price T Rowe Associates Inc. MD	1,099,329	$3.16M	0.0%	-10.4%	0.588%
5/15/2024	Avoro Capital Advisors LLC	18,650,000	$53.53M	0.6%	+328.2%	9.972%
5/14/2024	EntryPoint Capital LLC	122,905	$0.35M	0.3%	-57.9%	0.066%
5/14/2024	StemPoint Capital LP	1,087,785	$3.12M	0.8%	N/A	0.582%
5/10/2024	Acadian Asset Management LLC	26,477	$75K	0.0%	-94.2%	0.014%
5/10/2024	Vanguard Group Inc.	5,917,414	$16.98M	0.0%	-4.5%	3.164%
5/7/2024	Quantum Private Wealth LLC	698,520	$2.01M	0.7%	+9.2%	0.374%
4/29/2024	China Universal Asset Management Co. Ltd.	35,908	$0.10M	0.0%	+66.1%	0.019%
4/17/2024	Cannon Global Investment Management LLC	24,200	$69K	0.2%	N/A	0.013%
2/23/2024	Chicago Partners Investment Group LLC	134,851	$0.24M	0.0%	+21.4%	0.072%

Data available starting January 2016

See Full Table

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

Today's Range

Now: $1.93

$1.81

$1.95

50 Day Range

MA: $1.65

$1.48

$1.93

52 Week Range

Now: $1.93

$1.19

$4.32

Volume

1,561,698 shs

Average Volume

2,636,655 shs

Market Capitalization

$395.65 million

P/E Ratio

3.06

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Taysha Gene Therapies?: Taysha Gene Therapies' top insider investors include:
Paul B Manning (Major Shareholder)
RA Session II (Major Shareholder)
Sean P Nolan (CEO)
John A Stalfort III (Director)
Kamran Alam (CFO)
Sukumar Nagendran (Insider)
Learn More about top insider investors at Taysha Gene Therapies.
Who are the major institutional investors of Taysha Gene Therapies?: Taysha Gene Therapies' top institutional investors include:
Avoro Capital Advisors LLC — 9.76%
Octagon Capital Advisors LP — 5.10%
Vanguard Group Inc. — 4.35%
RTW Investments LP — 4.23%
Adage Capital Partners GP L.L.C. — 2.44%
Geode Capital Management LLC — 1.74%
Learn More about top institutional investors of Taysha Gene Therapies stock.
Which institutional investors are selling Taysha Gene Therapies stock?: In the last quarter, TSHA stock was sold by these institutional investors:
RTW Investments LP
VR Adviser LLC
Deutsche Bank AG
Acuta Capital Partners LLC
JPMorgan Chase & Co.
Marshall Wace LLP
ADAR1 Capital Management LLC
Los Angeles Capital Management LLC
Which institutional investors are buying Taysha Gene Therapies stock?: During the previous quarter, TSHA stock was bought by institutional investors including:
Octagon Capital Advisors LP
Adage Capital Partners GP L.L.C.
Bank of America Corp DE
Norges Bank
Avoro Capital Advisors LLC
B Group Inc.
Renaissance Technologies LLC
Vanguard Group Inc.
During the previous year, these company insiders have bought Taysha Gene Therapies stock:
Paul B Manning (Major Shareholder)
RA Session II (Major Shareholder)
Sean P Nolan (CEO)
John A Stalfort III (Director)
Learn More investors buying Taysha Gene Therapies stock.